Search

everythinglearnresearchcommunity

for

Search:↓

Three to five ovarian punctures are best for improving fertility in women with PCOS without harming the ovaries.

Women with idiopathic hirsutism and PCOS have higher RBP4 levels, and PCOS is linked to greater insulin resistance; weight management may help both conditions.

PSA might help diagnose PCOS and related skin issues, but more research is needed.

STK11 gene variations do not predict how well metformin will work for PCOS, but may affect hair loss and excess hair growth.

The guideline refines PCOS diagnosis, promotes a healthy lifestyle, reviews treatments, and stresses long-term follow-up.

Excessive hair growth affects the quality of life of Iranian women with PCOS the most.

Minoxidil can help transgender males grow facial hair before starting testosterone therapy.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

High levels of anti-Müllerian hormone can indicate polycystic ovarian syndrome in women who can have babies.

STK11 gene polymorphism does not predict metformin response in PCOS.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Sex hormones affect hair growth and loss, and treatments for related hair diseases include various medications, hair transplantation, and light therapy.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

Men with Kennedy disease have less chance of hair loss.

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.

Hyperandrogenism is a common hormonal disorder in women, often linked to PCOS.

Chromium salts may help with insulin sensitivity in PCOS, but more research is needed to confirm their overall effectiveness and safety.

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.

Eflornithine's effectiveness for women with facial hirsutism is unclear.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

Hirsutism in women is often due to hormone sensitivity and has significant psychological effects.

Most women referred for excess male hormone symptoms had polycystic ovary syndrome (PCOS), with other conditions being less common.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Experts agree that PCOS affects women's health in complex ways, but more research is needed to understand and treat it effectively.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

Oral contraceptives help treat hyperandrogenic disorders, improving symptoms like excessive hair and acne.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.